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A B S T R A C T
For some well-known pathogens like inﬂuenza or RSV, diagnostic and epidemiological data is available and
continuously complement each other. For most other pathogens however, data is not always available or se-
verely delayed. Furthermore, clinical data is needed to assess the burden of disease, which will enhance
awareness and help to gain knowledge on emerging pathogens. In this position paper, we discuss the inter-
dependence of diagnostics and epidemiology from a European perspective. In 2004, the European Centre for
Disease Prevention and Control (ECDC) was founded to coordinate European wide surveillance and control. At
present however, the ECDC still relies on university hospitals, public health institutions and other diagnostic
institutions. Close collaboration between all stakeholders across Europe is therefore complex, but necessary to
optimize the system for the individual patient. From the diagnostic side, data on detected pathogens should be
shared with relevant health institutions in real-time. From the public health side, collected information should
be made accessible for diagnostic and clinical institutions in real-time. Subsequently, this information needs to
be disseminated across relevant medical disciplines to reach its full potential.
1. Diagnostics as the source for clinical care and epidemiology
Every day, microbiological laboratories generate numerous diag-
nostic results. They provide crucial information regarding patient
management (e.g. treatment, isolation measures), indicating that di-
agnostic laboratories have a strong connection with clinical care pro-
viders across all specialisms. This information also provides a con-
tinuous update on the prevalence of pathogens and the treatment
options. It can be used to determine deviations and show trends, al-
though often in a retrospective manner. For some well-known patho-
gens such as inﬂuenza or RSV, this information is more readily avail-
able, sometimes even in real-time and on publicly available websites
[1]. For most pathogens however, this information is not available or
delayed. For instance, the “Surveillance Atlas of Infectious Diseases” by
the European Centre for Disease Control (ECDC) oﬀers a tool to vi-
sualise the prevalence of various pathogens [2]. For measles, informa-
tion is available on prevalence, number of deaths and even vaccine
status within several months. For other pathogens (such as MRSA,
MERS or hepatitis C), there is little to no data available on the pre-
valence over the recent years.
There are tools available which have the potential to be eﬀective in
tracking (emerging) pathogens. A recent paper by Edelstein et al. de-
scribes a set of principles to encourage the process of data sharing [3].
They discuss the importance of wider communication, good practice in
terms of the quality of the data and its dissemination, from an epide-
miologic perspective. Without communicating data, the true burden of
disease may stay unknown and upsurges could be missed or reported
late, when the information could be clinically not of any value any-
more. While delays are sometimes inevitable, initiatives have shown
that it is possible to publish the gathered data within a few weeks [4].
By combining diagnostic and clinical information in a more real-time
manner, the severity of emerging threats (i.e. in outbreak settings) can
be estimated in order to prepare and respond adequately. This should
involve both local and national institutions.
2. Epidemiology as the source for clinical care and diagnostics
For clinical practice, it is challenging to continuously select the right
sample, the right test, the right patient and the right time frame, par-
ticularly for emerging pathogens. These decisions rely on available di-
agnostic, clinical and epidemiological information to shape the case
deﬁnition. Using this information to direct the most appropriate route
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for infection management, is the essence of diagnostic stewardship [5].
Routine diagnostic data could be gathered and shared in a more com-
prehensive and rapid way, resulting in more accurate and up-to-date
epidemiologic data.
Importantly, dissemination of data between and within European
countries is highly challenging due to ﬁnancial and geographical var-
iation, as well as diﬀerences in health policies. The ECDC has been
established in 2005 to coordinate Europe-wide surveillance and control
of communicable disease. However, several limitations regarding in-
fectious disease surveillance have been reﬂected upon before, already
in 2008 [6]. We share these concerns, adding that they are still relevant
today. Without having centralized European reference laboratories, the
ECDC relies on information provided by university hospitals and re-
search institutions, which they also recognise in their long-term sur-
veillance strategy 2014–2020 [7]. A recent example is the EV-D68
outbreak in 2014, reﬂecting a close collaboration within the European
Society of Clinical Virology [8]. The informal but rapid type of colla-
boration and communication shown here, is particularly important
when little is known about the prevalence, which also varies between
countries. The low number of initial reported cases has led to an un-
derestimation of the real burden of disease [9].
During outbreaks of persistent or well-known pathogens, like during
the 2007 multi-country outbreak of Salmonella typhimurium DT104 in
Denmark and the Netherlands, there were well established channels for
international communication [10]. This ranged from local initiatives
such as Enter-net and Salm-gene (databases comprised of lab results with
epidemiological information and background levels), which were ra-
pidly disseminated to all relevant parties [11] right through to formal
communication such as the Early Warning and Response System
(EWRS) of ECDC [12]. Networks across several clinical disciplines can
take responsibility for the sharing of diagnostic and epidemiological
information, although often based on individual initiatives.
Questions also frequently arise whether diagnostics should be per-
formed for diseases without eﬀective treatment options. In general, for
respiratory diseases more attention is given to inﬂuenza and RSV, since
both can be treated in an acute setting. However, the outcome of re-
spiratory diagnostics is always informative, including results for pa-
thogens that cannot be treated at this point in time, or results that are
negative. Diagnostics are not only crucial for treatment, but also for
clinical awareness, patient management, infection control, as well as
epidemiological purposes e.g. to track trends and link speciﬁc clinical
presentations to a speciﬁc pathogen, to make risk assessments.
Furthermore, diagnostics could rule out pathogens, which helps to
optimize therapy, for example ceasing antibiotic treatment if a viral
pathogen is detected.
3. The current diagnostic network
Despite international eﬀorts have been made to strengthen in-
fectious disease surveillance in Europe for many decades, individual
countries, as well as the responsible national and international in-
stitutions are still unable to optimally use and share microbiological
data. The challenge is to organise a closer cooperation that invites
stakeholders across clinical, diagnostic and (public health) epide-
miology institutions to share information in a prospective and proactive
manner. As long as there are no centralized European reference la-
boratories, local initiatives are important for diagnostic laboratories, to
be beneﬁcial for the individual patient. As with EV-D68, it takes eﬀort
to involve this large group of stakeholders. Nevertheless, rapid, trans-
lational communication and data sharing between patient care, diag-
nostic and public health institutions could be established. Many dif-
ferent networks exist within the healthcare system, and each
stakeholder has its own perspective and responsibility (and interest),
which is essential for determining patient outcome. Therefore, we have
elaborated on the stakeholders and how data is communicated within
these networks (Fig. 1). As mentioned before, there is a strong
connection between diagnostic laboratories and clinical care providers,
who are the direct link to the patients. The connection between diag-
nostic laboratories and public health institutions is present, but often
only in one direction initially. Diagnostic information is used for epi-
demiological purposes, but in many cases this is not being used in real-
time to directly assist patient care, particularly when regarding lesser
known pathogens.
The patient remains the most important stakeholder. When a patient
visits a clinical care provider, a rapid and accurate diagnosis is crucial
for their recovery as well as for the impact on them and their family.
Clinical care providers are their ﬁrst and often only point of contact.
Clinical laboratories are the link to the clinical care provider by de-
veloping and performing diagnostic tests: Diagnostic Stewardship.
Results of routine diagnostics are used to guide treatment for the re-
covery of the patient: Antimicrobial Stewardship. In addition to this, di-
agnostics could also assist patient management to prevent further in-
fections: Infection Prevention Stewardship. All together, they comprise
the concept of AID-stewardship, as described before [5]. However, there
is no real-time link to epidemiological data, speciﬁcally the feedback of
epidemiological data into diagnostic practices in the case of an emer-
ging pathogen. This should contain detailed knowledge on circulating
pathogens, which allows health care providers to anticipate on the
current situation by means of prevention strategies and diagnosis.
4. Perspectives based on current networks and initiatives
With this position paper, we envision a closer and stronger con-
nection of information generated by clinical care providers (clinical
data), clinical laboratories (diagnostic data) and public health institutes
(epidemiological data). As shown in Fig. 1, the diagnostic parties are
the link in this spectrum, and could therefore act as the designated
stakeholder to take the lead and act proactively within this network. As
clinical laboratories continuously generate diagnostic data, they could
assess rather quickly whether an emerging pathogen is present, or if
there are ﬂuctuations in persistent pathogens such as changes in base-
line prevalence, susceptibility or pathology. Subsequently, data can be
shared with other stakeholders, for example university hospitals, re-
gional diagnostic centres for infectious diseases and public health in-
stitutes on a weekly or biweekly basis, to create a feedback loop of
information.
To reach such a situation, there is one crucial condition needed: real
time reporting and sharing of epidemiological information by (National
and International) laboratories. These institutes should act together as a
focus point for communicating their collected diagnostic information.
Of course, the delay in the availability of information, as well as privacy
concerns may complicate data sharing. It is also diﬃcult to implement
frequent reporting or to manage emerging outbreaks in a multi-country
Fig. 1. Microbiology diagnostic network. Arrows representing the interac-
tions between stakeholders including the direction. The more arrows the more
interaction.
M.K. van Genne, et al. Journal of Clinical Virology 118 (2019) 6–8
7
setting, knowing that the diagnostic capacity is diﬀerent and often
diﬃcult to perform in the European countries. Indeed, determining the
exact burden of an emerging pathogen is particularly diﬃcult; this can
be due to low circulation generally in the community or to inadequate
testing, fuelling a vicious cycle of low numbers found. Current (rapid)
risk assessments still have a retrospective character, rather than pro-
spective. This kind of communication does not reach clinical care
providers, and will therefore not help the ﬁeld move forward during
rapid upsurges.
Epidemiological data should also be more easily accessible and
manageable. A good and visual example is the HealthMap Initiative,
developed by a group of researchers, epidemiologists, and software
developers at the Boston Children’s Hospital [13]. HealthMap monitors
outbreaks and other public health threats by accumulating online in-
formal health information. Visitors can immediately select a country to
see the latest news in that region. The data can be as recent as 24 h and
is accessible to everyone. The downside is that HealthMap depends on
news sites to share the information ﬁrst. Similar open access, custom
web-based platforms are available as well, for instance nextrain.org
[14]. It would be beneﬁcial to have the diagnostic data available on a
similar public database directly. A further example of an existing public
database is MSIS, the Norwegian Surveillance System for Communic-
able Diseases. By law, clinicians must report from a list of nearly 70
notiﬁable diseases which then would be made publicly available online
[15]. Furthermore, tools are available on the website to make your own
tables and perform statistics, however it does note that there can be
delays in reporting. EPIS (Epidemic Intelligence Information System) by
the ECDC, oﬀers an online platform for public health experts, nomi-
nated by EU Member States, to communicate and to determine the
impact of current and emerging threats [16]. Additional platforms of-
fered by the ECDC include EWRS and tESSY. However, this content is
not accessible for all routine diagnostic parties, which delays the
sharing of useful information. Furthermore, these databases only ad-
dress diagnostic results and can be outdated, even for years. Ideally,
some general clinical and epidemiological information should be in-
cluded as well, to accurately estimate the severity of the threat. On the
diagnostic side, even when only looking at respiratory viruses, many
initiatives to share data do exist. For example, the RespVir network [17]
based in Germany and TypeNed [18] in the Netherlands. In the United
States, the CDC provides a clear view on recent inﬂuenza activity on
both national and state level, which is publicly available [19]. Finally,
also commercial partners of syndromic point-of-care systems are al-
ready implementing online databases, where diagnostic results are
uploaded in real-time, e.g. www.syndromictrends.com or www.
rsvalert.com [20,21]. These initiatives are good examples which show
that it is possible to utilise data in an optimal manner.
5. The take home message
Driven by local initiatives, responsibility should be taken collec-
tively to structurally create symbiosis between patient care, diagnostics
and public health epidemiology. Interdisciplinary dissemination of re-
levant diagnostic, epidemiologic and clinical information should be
used for epidemiological analysis in real time, which in turn can be
used by diagnostic laboratories to be beneﬁcial for the individual pa-
tient. Diagnostic laboratories should routinely share data to public
health institutes in a timely manner, while these institutes should make
that data available and accessible in real-time for the relevant diag-
nostic laboratories and clinical care providers. This system could be
accessed to visualise trends and will be instrumental for preparedness
and outbreak response.
Additionally, the available data should preferably be combined with
clinical information, since this adds relevance to the diagnostic data.
After all, a single detection with a unique clinical presentation can al-
ready have a signiﬁcant impact.
In conclusion, all involved stakeholders share the responsibility to
ensure that the available diagnostic, epidemiological and clinical in-
formation reaches its full potential. Translation, communication and
interpretation between disciplines is essential in advancing healthcare.
A prerequisite for this is that the responsible European institutions need
to add more pathogens to their portfolio. By making use of the nu-
merous advanced technologies (e.g. artiﬁcial intelligence, data mining,
machine learning) that are currently available, we should be able to
predict future trends and understand more about transmission routes
and pathology, particularly in emerging pathogens. A strong European
surveillance network should after all be beneﬁcial for the most im-
portant stakeholder: the patient.
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